Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Potential target antigens for immunotherapy in human pancreatic cancer.
Schmitz-Winnenthal FH, Galindo-Escobedo LV, Rimoldi D, Geng W, Romero P, Koch M, Weitz J, Krempien R, Niethammer AG, Beckhove P, Buchler MW, Z'graggen K. Schmitz-Winnenthal FH, et al. Among authors: krempien r. Cancer Lett. 2007 Jul 18;252(2):290-8. doi: 10.1016/j.canlet.2007.01.003. Epub 2007 Feb 22. Cancer Lett. 2007. PMID: 17320278
Multidrug resistance-1 (MDR-1): a new target for T cell-based immunotherapy.
Niethammer AG, Wodrich H, Loeffler M, Lode HN, Emmerich K, Abdollahi A, Krempien R, Debus J, Huber PE, Reisfeld RA. Niethammer AG, et al. Among authors: krempien r. FASEB J. 2005 Jan;19(1):158-9. doi: 10.1096/fj.04-2355fje. Epub 2004 Oct 21. FASEB J. 2005. PMID: 15498893
Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759].
Knaebel HP, Märten A, Schmidt J, Hoffmann K, Seiler C, Lindel K, Schmitz-Winnenthal H, Fritz S, Herrmann T, Goldschmidt H, Krempien R, Mansmann U, Debus J, Diehl V, Büchler MW. Knaebel HP, et al. Among authors: krempien r. BMC Cancer. 2005 Apr 12;5:37. doi: 10.1186/1471-2407-5-37. BMC Cancer. 2005. PMID: 15826316 Free PMC article. Clinical Trial.
Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283].
Krempien R, Muenter MW, Huber PE, Nill S, Friess H, Timke C, Didinger B, Buechler P, Heeger S, Herfarth KK, Abdollahi A, Buchler MW, Debus J. Krempien R, et al. BMC Cancer. 2005 Oct 11;5:131. doi: 10.1186/1471-2407-5-131. BMC Cancer. 2005. PMID: 16219105 Free PMC article. Clinical Trial.
Intraoperative radiotherapy for rectal carcinoma.
Treiber M, Oertel S, Weitz J, Krempien R, Bischof M, Wannenmacher M, Büchler M, Debus J. Treiber M, et al. Among authors: krempien r. Recent Results Cancer Res. 2005;165:238-44. doi: 10.1007/3-540-27449-9_26. Recent Results Cancer Res. 2005. PMID: 15865039 Review. No abstract available.
Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.
Krempien R, Roeder F, Oertel S, Roebel M, Weitz J, Hensley FW, Timke C, Funk A, Bischof M, Zabel-Du Bois A, Niethammer AG, Eble MJ, Buchler MW, Treiber M, Debus J. Krempien R, et al. Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1143-51. doi: 10.1016/j.ijrobp.2006.06.008. Epub 2006 Sep 18. Int J Radiat Oncol Biol Phys. 2006. PMID: 16979835 Clinical Trial.
Intraoperative electron radiotherapy for the management of aggressive fibromatosis.
Roeder F, Timke C, Oertel S, Hensley FW, Bischof M, Muenter MW, Weitz J, Buchler MW, Lehner B, Debus J, Krempien R. Roeder F, et al. Among authors: krempien r. Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1154-60. doi: 10.1016/j.ijrobp.2009.03.067. Epub 2009 Aug 3. Int J Radiat Oncol Biol Phys. 2010. PMID: 19647952
Intraoperative electron boost radiation followed by moderate doses of external beam radiotherapy in limb-sparing treatment of patients with extremity soft-tissue sarcoma.
Oertel S, Treiber M, Zahlten-Hinguranage A, Eichin S, Roeder F, Funk A, Hensley FW, Timke C, Niethammer AG, Huber PE, Weitz J, Eble MJ, Buchler MW, Bernd L, Debus J, Krempien RC. Oertel S, et al. Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1416-23. doi: 10.1016/j.ijrobp.2005.10.009. Epub 2006 Jan 18. Int J Radiat Oncol Biol Phys. 2006. PMID: 16413697
A clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma.
Roeder F, Schulz-Ertner D, Nikoghosyan AV, Huber PE, Edler L, Habl G, Krempien R, Oertel S, Saleh-Ebrahimi L, Hensley FW, Buechler MW, Debus J, Koch M, Weitz J, Bischof M. Roeder F, et al. Among authors: krempien r. BMC Cancer. 2012 Jul 12;12:287. doi: 10.1186/1471-2407-12-287. BMC Cancer. 2012. PMID: 22788989 Free PMC article. Clinical Trial.
110 results